Advertisement
U.S. markets closed

United-Guardian, Inc. (UG)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
7.65+0.14 (+1.86%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close7.51
Open7.60
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.51 - 7.65
52 Week Range5.79 - 10.25
Volume10,058
Avg. Volume9,414
Market Cap35.147M
Beta (5Y Monthly)0.72
PE Ratio (TTM)13.66
EPS (TTM)0.56
Earnings DateMay 09, 2024 - May 13, 2024
Forward Dividend & Yield0.35 (4.58%)
Ex-Dividend DateFeb 09, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for UG

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • United-Guardian, Inc.
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • Simply Wall St.

    Estimating The Intrinsic Value Of United-Guardian, Inc. (NASDAQ:UG)

    Key Insights United-Guardian's estimated fair value is US$6.95 based on 2 Stage Free Cash Flow to Equity With US$7.76...

  • GlobeNewswire

    United-Guardian Reports 2023 Financial Results

    HAUPPAUGE, N.Y., March 22, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported that net income for FY 2023 remained relatively flat compared to FY 2022. Net sales for the year decreased by 14% from $12,698,503 in 2022 to $10,885,154 in 2023, generating net income of $2,581,370 ($0.56 per share) in 2023 compared to $2,569,512 ($0.56 per share) in 2022. Donna Vigilante, President of United-Guardian, stated, “While net income remained flat from 2022 to 2023, we did experience a decr

  • GlobeNewswire

    United-Guardian Announces Dividend Increase

    HAUPPAUGE, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on January 30, 2024, declared a cash dividend of $0.25 per share, to be paid on February 20, 2024, to all stockholders of record as of the close of business on February 12, 2024. This will be the 29th consecutive year that the company has paid a dividend. Donna Vigilante, President of United-Guardian, stated, “I am pleased to report that the c